In summary, ZVS-08 and 1 were able to reduce the growth of cancer cells expressing KV10.1 but were much less active on cells expressing hERG or on normal cells, suggesting that their effect on KV10.1 serves more to inhibit growth in these cells. This evidence concerns the gene KCNH2 and cancer.